Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01607216 · ClinicalTrials.gov registry record
Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
A clinical trial of Bronchopulmonary Dysplasia and Prematurity, sponsored by University of Rochester.
- Completed
- Registry status
- 277
- Enrollment target
- 2
- Study locations
NCT01607216: Completed study of Bronchopulmonary Dysplasia and Prematurity, sponsored by University of Rochester.
NCT01607216 is a study of Bronchopulmonary Dysplasia and Prematurity that has completed, run by University of Rochester. The registered enrollment target is 277 participants, above the 227-participant average among 29 other Bronchopulmonary Dysplasia trials with a reported enrollment target (22% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01607216, a study of Bronchopulmonary Dysplasia and Prematurity, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 277 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is an observational study that proposes to collect clinical, physiological, cellular and molecular information in an attempt to identify a set of factors that may predict the risk for persistent lung disease in babies born prematurely.
Primary Outcome
The primary goal of the PROP studies (single center and multicenter protocols) is to identify biomarkers (biochemical, physiological and genetic) and clinical variables that are associated with and thus potentially predictive of pulmonary status in preterm infants up to 1 year corrected age. We propose a composite primary outcome of SRD that is based on serial parental reports of respiratory symptoms, medications, hospitalizations and dependence on technology during the first year of life.
Conditions Studied
Study Locations (2)
New York
- Women and Children's Hospital of Buffalo - Buffalo
- University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 277 participants |
| Start Date | 2011-08 |
| Est. Completion | 2015-07 |
What the finished NCT01607216 record still lists
NCT01607216 is an observational study that tracks outcomes without assigning an intervention. The registered 277 participants enrollment target is mid-sized for trials with a published cap, above the 227-participant average among 29 other Bronchopulmonary Dysplasia trials with a reported enrollment target (22% higher).
The record links to 3 conditions, with Bronchopulmonary Dysplasia appearing as the primary indexed condition, and to 0 interventions.
NCT01607216 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01607216 about?
NCT01607216 is a clinical study titled "Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies". This is an observational study that proposes to collect clinical, physiological, cellular and molecular information in an attempt to identify a set of factors that may predict the risk for persistent lung disease in babies born prematurely.
What is the current status of trial NCT01607216?
This trial is currently completed. The enrollment target is 277 participants. The study started on 2011-08. Estimated completion is 2015-07.
What conditions does trial NCT01607216 study?
This clinical trial studies the following conditions: Bronchopulmonary Dysplasia, Prematurity, Symptomatic Respiratory Disease.
Who is sponsoring clinical trial NCT01607216?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01607216 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bronchopulmonary Dysplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01607216's enrollment target sits among peer trials
277 10th of 29 higher than 20 of 29 other Bronchopulmonary Dysplasia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bronchopulmonary Dysplasia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
RECRUITING · NA
-
Multidimensional Phenotype Classification in Grade 3 Bronchopulmonary Dysplasia
RECRUITING
-
Genesis Electrical Impedance Tomography (EIT): A Preliminary Study
RECRUITING
-
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
RECRUITING · Phase 2
-
Forced Oscillometry in Infants With Bronchopulmonary Dysplasia
RECRUITING
-
Transpyloric Versus Gastric Feeding in Bronchopulmonary Dysplasia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05818683 · 277 participants · Phase 1
A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer
- NCT06789913 · 277 participants · Phase 2
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation
- NCT04586959 · 278 participants · NA
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
- NCT05010148 · 278 participants · Phase 3
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia